St3Gal Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of St3Gal monoclonal antibodies for advanced research in glycosylation and its implications in various biological processes. St3Gal monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). St3Gal, or sialyltransferase, plays a critical role in the addition of sialic acid to glycoproteins and glycolipids, influencing cell-cell interactions, immune response, and pathogen recognition. Understanding St3Gal function is essential for elucidating its involvement in various diseases, including cancer and neurodegenerative disorders. The study of St3Gal and associated pathways can provide insights into therapeutic targets and biomarker development. Research into St3Gal activity has revealed significant implications for cellular signaling and disease progression. Investigating St3Gal mechanisms has opened new avenues for understanding glycobiology and its impact on human health. St3Gal research continues to uncover novel aspects of protein modification and cellular communication. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of St3Gal's role in health and disease.